CD86 and cancer: (217) demonstrated that ferumoxytol, a drug used in treatment of iron deficiency anemia, induced the upregulation of CD86 and TNF-α (M1 macrophage) markers in RAW264.7 macrophages co-cultured with MMTV-PyMT cancer cells.